Bristol-Myers, Pfizer's Eliquis Approved in Japan

Published December 26, 2012

Bristol-Myers, Pfizer's Eliquis approved in Japan

Filed under: drug treatment programs nj

TRENTON, N.J. (AP) — Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart …
Read more on The Associated Press

Stocks InThe News (DNDN, LOW, GNW, TSN, SID)

Filed under: drug treatment programs nj

Dendreon's Morris Plains, New Jersey, facility is a 173,100 square foot state-of-the-art IMF, featuring revolutionary capabilities to manufacture PROVENGE® (sipuleucel-T), the first autologous cellular immunotherapy to receive U.S. Food and Drug …
Read more on Mesh Press (press release)

Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 3 Study of CPX …

Filed under: drug treatment programs nj

The Phase 3 study is being conducted in partnership with The Leukemia & Lymphoma Society(R) (LLS) which has supported the development of CPX-351, beginning in Phase 2, through its Therapy Acceleration Program (TAP)(TM). … CPX-351 has been granted …
Read more on MarketWatch (press release)